Comparison of Cilostazol and Ticlopidine for One-Month Effectiveness and Safety after Elective Coronary Stenting

Author： Hashiguchi Masayuki   Ohno Keiko   Nakazawa Rieko   Kishino Satoshi   Mochizuki Mayumi   Shiga Tsuyoshi  

Publisher： Springer Publishing Company

ISSN： 0920-3206

Source： Cardiovascular Drugs and Therapy, Vol.18, Iss.3, 2004-05, pp. : 211-217

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cilostazol outperforms ticlopidine after coronary stenting

By  

Inpharma, Vol. 1, Iss. 1509, 2005-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

Clopidogrel vs ticlopidine: tolerability after coronary stenting

By  

Inpharma, Vol. 1, Iss. 1436, 2004-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

Clopidogrel an alternative to ticlopidine in coronary stenting

By  

Inpharma, Vol. 1, Iss. 1223, 2000-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite

Comparison of Ticlopidine and Aspirin versus Clopidogrel and Aspirin after Percutaneous Coronary Interventions in High-Risk Patients

By  

Heart Drug, Vol. 5, Iss. 4, 2005-12 ,pp. : 187-192

Karger

Access to resources Recommend Favorite

Clopidogrel + eptifibatide CLEARs PLATELETS after coronary stenting

By  

Inpharma, Vol. 1, Iss. 1480-1481, 2005-01 ,pp. : 16-16

Adis International

Access to resources Recommend Favorite